Cargando…
What are the roles of global DNA and APC 2 gene promotor hypermethylation in multiple myeloma?
BACKGROUND: In today's practice, gene-based approaches come to the fore in the determination of prognosis and treatment preferences of multiple myeloma (MM). DNA methylation is one of the new approach parameters. DNA methylation occurs by the addition of a methyl group to cytosines in CpG dinuc...
Autores principales: | Pehlivan, Sacide, Serin, Istemi, Nursal, Ayse Feyda, Oyaci, Yasemin, Gundes, Ilknur, Pehlivan, Mustafa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505470/ https://www.ncbi.nlm.nih.gov/pubmed/34637096 http://dx.doi.org/10.1007/s11033-021-06813-z |
Ejemplares similares
-
The miRNA 196a2 rs11614913 variant has prognostic impact on Turkish patients with multiple myeloma
por: Kirik, Melya Pelin, et al.
Publicado: (2020) -
A new parameter in multiple myeloma: CYP3A4*1B single nucleotide polymorphism
por: Serin, Istemi, et al.
Publicado: (2020) -
Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience
por: Taş Ozyurtseven, Betul, et al.
Publicado: (2021) -
Epigenetic and genetic investigation of SOCS-1 gene in patients with multiple myeloma
por: Tuncel, Fatıma Ceren, et al.
Publicado: (2022) -
PB2075: HOW EFFECTIVE ARE LEPTIN GENE POLYMORPHISMS AND METHYLATION DURING THE COURSE OF MULTIPLE MYELOMA (MM)?
por: Serin, Istemi, et al.
Publicado: (2023)